Trial intelligence / Profile preview

Effect of Central Nervous System Stimulants on Physical Function in Children With Cerebral Palsy

NCT05675098Phase 1Not yet recruiting

Sponsor
Kuwait University
Start
May 2023
Primary completion
Feb 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, triple-blind trial in cerebral palsy (CP) comparing Methylphenidate, Modafinil and Placebo (3 arms). Primary endpoints: Gross Motor Function Measure at 24 weeks and Modified Ashworth Scale at 24 weeks. Planned start May 2023; status: not yet recruiting.

02

Drugs

methylphenidatemodafinil
03

Conditions

cerebral palsy (CP)

Beyond the preview

Go deeper on NCT05675098.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05675098.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call